Inflationary pressures as well as the COVID-19 pandemic’s continuing impact on transportation and supplies are obvious in Johnson & Johnson’s latest consumer health business results, its plans to raise prices for products and its forecast for 2022.
The influence of increasing costs coupled with shipping delays and labor shortages isn’t reaching its plans to separate the consumer...






